MENU
+Compare
SRTS
Stock ticker: NASDAQ
AS OF
Jun 6, 04:59 PM (EDT)
Price
$4.92
Change
-$0.11 (-2.19%)
Capitalization
61.97M

SRTS Sensus Healthcare Forecast, Technical & Fundamental Analysis

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system... Show more

SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SRTS with price predictions
Jun 05, 2025

SRTS's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for SRTS moved out of oversold territory on May 06, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 30, 2025. You may want to consider a long position or call options on SRTS as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SRTS just turned positive on May 09, 2025. Looking at past instances where SRTS's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

SRTS moved above its 50-day moving average on May 19, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRTS crossed bullishly above the 50-day moving average on May 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTS advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where SRTS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRTS broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRTS entered a downward trend on May 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.269) is normal, around the industry mean (24.191). P/E Ratio (126.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.520) is also within normal values, averaging (42.393).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

View a ticker or compare two or three
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SRTS is expected to report earnings to fall 106.25% to 0 cents per share on July 31

Sensus Healthcare SRTS Stock Earnings Reports
Q2'25
Est.
$0.01
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.08
The last earnings report on May 15 showed earnings per share of -15 cents, missing the estimate of 5 cents. With 42.74K shares outstanding, the current market capitalization sits at 61.97M.
A.I. Advisor
published General Information

General Information

a manufacturer of skin cancer treatment products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
851 Broken Sound Parkway, NW
Phone
+1 561 922-5808
Employees
35
Web
https://www.sensushealthcare.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRD1.040.04
+4.00%
Opus Genetics Inc
NL7.010.11
+1.59%
NL Industries
PBF18.360.25
+1.38%
PBF Energy
APH93.360.84
+0.91%
Amphenol Corp
USLM106.15-0.18
-0.17%
United States Lime & Minerals

SRTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+2.86%
LUNG - SRTS
57%
Loosely correlated
-3.90%
VAPO - SRTS
35%
Loosely correlated
N/A
PLSE - SRTS
34%
Loosely correlated
-7.04%
TWST - SRTS
28%
Poorly correlated
-0.36%
BFLY - SRTS
28%
Poorly correlated
-1.67%
More